BioFactura

BioActura Develops StableFast Biomanufacturing Platform, a New System for Rapid Generation of Stable NS0 Cell Lines for Biopharmaceutical Manufacturing. The system's components include chemically defined, serum-free and cholesterol-free media, pre-adapted parental cells, modular expression vectors utilizing patented selection strategies, and proprietary growth supplements that enable rapid generation and cloning of cell lines. This platform is simple, fast, and efficient to use. A clonal production cell line can be developed and scaled up to produce over one gram of product in less than eight weeks.